PRAME expression and clinical outcome of breast cancer

le Epping, M T, Hart, A A M, Glas, A M, Krijgsman, O, Bernards, R
Foilsithe 2008

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

le Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van 't Veer, L J
Foilsithe 2003

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

le Kaas, R, Peterse, J L, Hart, A A M, Voogd, A C, Rutgers, E J T, van Leeuwen, F E
Foilsithe 2003

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

le Bijker, N, Peterse, J L, Fentiman, I S, Julien, J-P, Hart, A A M, Avril, A, Cataliotti, L, Rutgers, E J T
Foilsithe 2002

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

le Hoebers, F. J. P., Pluim, D., Hart, A. A. M., Verheij, M., Balm, A. J. M., Fons, G., Rasch, C. R. N., Schellens, J. H. M., Stalpers, L. J. A., Bartelink, H., Begg, A. C.
Foilsithe 2007